Search results for “Enzyme inhibitor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 30,932 patents, we discovered top 473 key players by total patent application. Novartis AG, Merck & Co., Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 8.28% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 1,064
Merck & Co., Inc.
New Jersey, United States
Patent: 806
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 692
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 655
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 582
Smithkline Beckman Corp
Pennsylvania, United States
Patent: 578
Bristol Myers Squibb Co.
New York, United States
Patent: 569
Pfizer Inc.
New York, United States
Patent: 447
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 428
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 404
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 259 patents, we discovered top 52 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, SyntheX, Inc., NiKang Therapeutics, Inc. are active in this area.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 45
STARTUP
SyntheX, Inc.
California, United States
Patent: 34
STARTUP
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 21
STARTUP
iOmx Therapeutics AG
Bayern, Germany
Patent: 9
STARTUP
Atriva Therapeutics GmbH
Baden-Württemberg, Germany
Patent: 9
STARTUP
Step Pharma SAS
France
Patent: 8
STARTUP
Mycovia Pharmaceuticals, Inc.
North Carolina, United States
Patent: 7
STARTUP
Akarna Therapeutics Ltd.
Buckinghamshire, United Kingdom
Patent: 7
STARTUP
Xynomic Pharmaceuticals, Inc.
California, United States
Patent: 7
STARTUP
Aventis, Inc.
New Jersey, United States
Patent: 6
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 3,063 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Array BioPharma, Inc., BASF AB, Jiangsu Hengrui Pharmaceuticals Co., Ltd. take 4.28% of patent filing during this period.
Array BioPharma, Inc.
Colorado, United States
Patent: 46
BASF AB
Sweden
Patent: 43
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 42
Gilead Sciences, Inc.
California, United States
Patent: 41
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 40
KalVista Pharmaceuticals Ltd.
United Kingdom
Patent: 35
Incyte Corp.
Delaware, United States
Patent: 35
BIAL-Portela & Cia SA
Porto, Portugal
Patent: 34
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 27
Monsanto Technology LLC
Missouri, United States
Patent: 23
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 3,063 patents in last 5 years, we discover 202 new entrants. NiKang Therapeutics, Inc., Suzhou Suncadia Biopharmaceuticals Co., Ltd., Zhuhai Yufan Biotechnologies Co., Ltd are the most active new entrants in this area.
STARTUP
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 21
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 17
Zhuhai Yufan Biotechnologies Co., Ltd
China
Patent: 16
Medipure Pharmaceuticals, Inc.
British Columbia, Canada
Patent: 11
University of Basel
Basel-Stadt, Switzerland
Patent: 10
Lynk Pharmaceuticals Co. Ltd.
Zhejiang Sheng, China
Patent: 9
Jiangxi Caishi Pharmaceutical Technology Co., Ltd.
Jiangxi Sheng, China
Patent: 9
Taigen Pharmaceutical R & D (Beijing) Co Ltd
Beijing Shi, China
Patent: 9
STARTUP
iOmx Therapeutics AG
Bayern, Germany
Patent: 9
Crystal Pharmaceutical (Suzhou) Co., Ltd
Jiangsu Sheng, China
Patent: 8
Research Institutions
Order by:
Innovation Intensity
With the analysis among 3,793 patents, we discovered top 280 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of Miami, The Johns Hopkins University are dominant in this area. They take 7.59% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 91
University of Miami
United States
Patent: 48
The Johns Hopkins University
United States
Patent: 44
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 43
The Scripps Research Institute
California, United States
Patent: 38
Duke University
North Carolina, United States
Patent: 34
Emory University
Georgia, United States
Patent: 34
President & Fellows of Harvard College
Massachusetts, United States
Patent: 28
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 27
Jilin University
Jilin Sheng, China
Patent: 27
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: